Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Johnson and Johnson
AstraZeneca
Medtronic
McKesson

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Drug Sales Trends for MOXEZA

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Payment Methods and Pharmacy Types for MOXEZA (2017)

Revenues by Pharmacy Type

Pharmacy Type Revenues
INSIDE ANOTHER STORE $2,991,039
INSIDE HMO/CLINIC/HOSPITAL $1,302,641
[disabled in preview] $5,214,794
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
INSIDE ANOTHER STORE 12,602
INSIDE HMO/CLINIC/HOSPITAL 5,489
[disabled in preview] 21,972
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $901,347
PRIVATE INSURANCE $3,931,863
[disabled in preview] $4,675,264
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for MOXEZA
Drug Units Sold Trends for MOXEZA

Annual Sales Revenues and Units Sold for MOXEZA

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
MOXEZA   Start Trial   Start Trial 2017
MOXEZA   Start Trial   Start Trial 2016
MOXEZA   Start Trial   Start Trial 2015
MOXEZA   Start Trial   Start Trial 2014
MOXEZA   Start Trial   Start Trial 2013
MOXEZA   Start Trial   Start Trial 2012
MOXEZA   Start Trial   Start Trial 2011
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Moodys
Medtronic
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.